Schedule an Appointment

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.
   
Book a Conference Call
Get More Information

EXtatin Inc.

Location: Toronto, Ontario Sector: Life Science  
Add to Shortlist
Express Interest

EXtatin is involved in the research and development of a bio compatible molecule to be introduced topically and sub-dermally in order to facilitate the detachment and disposal of tattoo ink laden cells. The experiments and research are being conducted on live tattooed skin from donors who have undergone surgical excision of the tattooed skin as part of plastic and cosmetic surgery procedures.

Business Documents

MG cp Summary
  • Quality research and Management – Dr. Sheldon Joseph PhD is a qualified cell physiologist with experience cancer research and genetics. He is the principle investigator for the research and development of the company . Frederick Hawa is litigation lawyer (Osgoode) with a BSc (U of T) and MBA (Miami) who has many years of experience in the biotechnology R and D world
  • Immediate Investor interest – Extatin has a core of 50 or so interested individual investors who are prepared to invest $30,000 to $50,000 each should the company fulfill its goals of providing shares which can be traded on the public markets.

EXtatin is involved in the research and development of a bio compatible molecule to be introduced topically and sub-dermally in order to facilitate the detachment and disposal of tattoo ink laden cells. The experiments and research are being conducted on live tattooed skin from donors who have undergone surgical excision of the tattooed skin as part of plastic and cosmetic surgery procedures.

Sheldon Mark Joseph, Ph.D., Co-Founder, Director, Principal Investigator – Sheldon is a creative, resourceful, vibrant, US and UK-trained entrepreneurial scientist. Following his Bachelor of Science (Salutatorian, Summa Cum Laude, Morehouse/HHWI Scholarships, Golden Key Most Outstanding Senior, Phi Beta Kappa, National Deans’ Lists) in Biology (with Honors) at Morehouse College (GA), which included independent research at Lancaster University (Fylde Scholar, UK), he pursued a decorated internship at the Merck Research Laboratories Inc. (NJ) where he earned the title: Most Outstanding Intern. Sheldon continued his award-winning academic career, bypassing the Masters to earn his Ph.D. in Cell Physiology in the Department of Physiology and Biophysics at Case Western Reserve University and the Cleveland Clinic (OH).   While there he earned the Richard O. Recknagel Prize for Best Academic Record and won multiple international research symposia and speaking awards. He then trained as a Post-Doctoral Fellow in Cancer Genetics at the world-renowned Roswell Park Cancer Institute, Center of Excellence (NY). Sheldon is a multi-published scientist and is a sought-after independent Life Sciences Professor and Lecturer at various institutes of higher learning in the Greater Toronto Area, including the University of Toronto’s School of Continuing Studies.   Frederick Simon Hawa, MBA LLB (JD), Co-founder, Business Development Consultant – Frederick is an internationally experienced, entrepreneurial, Toronto-based Barrister who specializes in civil litigation and biotechnology. He earned his Bachelor of Science (with Honors) at the University of Toronto, and continued his successful academic career by earning his MBA (International Business) and LLB (JD) at the University of Miami and York University’s Osgoode Hall.